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A M-length 1,209 bp cDNA encoding the human sex steroid-binding protein of plasma (SBP or SHBG) and testis (ABP) was cons~ructi and 
expressed in BHK-21 cells. The sequence agrees with the published gene and protein sequences. The cells were found to secrete SBP following 
transfection and G418’ selcctior:. The recombinant protein binds Sol-dihydrotestosteronc with a Kd of 0.28 nM. It also binds testosterone and 
17b-cstradiol but not progesterone, estrone or cortisol revealing asteroid-binding sjxciiicity identical to that of human SBP. SDS-PAGE patterns 
are less complex than human SBP and show a monomeric molecular weight of about 43 kDa. 
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1. INTRODUCTION 
The sex steroid-binding protein, SBP (or SHBG, sex 
hormone binding globulin), of human plasma specifi- 
cally binds testosterone (T) and 17@stradiol (EP) with 
high affinity (see [l] for most recent comprehensive 
review). Human SBP was extensively characterized and 
sequenced by protein sequencing methods [2]. The 
human SBP gene was cloned [3,4] and the coding se- 
quence is identical to that of a cDNA clone coding for 
the human testis androgen-binding protein (ABP). A 
number of partial human SBP cDNAs have been cloned 
[5-71 and their deduced amino acid sequences agree with 
the sequence obtained by direct protein sequencing 
methods, except for Leu259 which is reported to be 
Phezs9 by Hammond et al. [4,6]. This laboratory is inter- 
ested in describing the molecular structure of SBP/ABP 
for understanding both the specific and general features 
of steroid-protein interaction and the role of the protein 
in the transport of sex steroid hormones. In order to 
apply site-directed mutagenesis to the understanding of
SBP structure and function, we have constructed a full- 
length SBP cDNA and expressed it in mammalian cells, 
and have begun to characterize the recombinant pro- 
tein. 
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2. MATERIALS AND METHODS 
DHIOB E. co/i was from Gibco-BRL, pBluescript II nnd SURE E. 
cu/i cells were from Stratagene, and pcDNrVNeo and MC10611p3 E. 
culi cells were from Invitroyn. Golden hamster kidney cells (BHK-21, 
eF-7697) and Hep G2 cells (~8065) were from ATCC. Hep G2 cells 
wcrc grown in MEM and 9% PBS (Gibco-BRL), 2 mM L-glutamine, 
I mM sodium pyruvatc and 0.1 mM non-essential mino acids. BHK- 
21 cells were grown in SO ml hsks containing Dulbccco’s MEM with 
10% FBS. poly(A)’ RNA was prepared from Hep G2 cells [S] and 
first-strand cDNA was synthesized with random and oligodT primers. 
SBP cDN:\ was amplified using the GeneAmp kit (Pcrkin Elmer 
Cetus) with I ng each of random-primed and oligo dT primed cDNA 
template. Amplification was dcne in lhe Perkin Elmer Cetus Thermo- 
cyclcr for 25 cycles at 94’C for 2 min and 72°C for 2 min. PCR 
products were cloned into pDVEG’ or pVEGT’ and sequenced [9] 
using “S-dATP from DuPonVNEN [IO] with the protocol oKhen and 
Sceburg [l l] using T7 DNA polymerase (U.S.B.) [Ia] and were primed 
with a universal primer or with oligonuclcotides complementary to
PCR-generated sequences. Oligonucleotidcs were synthesized on an 
Applied Biosystcms model 380A DNA synthesizer. Probes for 
Southern blots were fragments 1.2 and 3 labelcd with biotin-MdATP 
using random oligonuclcotidc-primed synthesis f13] according LO 
published protocols 1141. Agarosc gels were blotted onto nylon 
membranes (S & S Nytran, Schlcicher & Schuell) according to 
Southern [IS]. The blots were probed with a mixture of the three 
biotinylated fragments and developed with strcptavidin and biotin- 
conjugated alkaline phosphatasc. Partial digestion with EcoRl was 
with 0.5 U, 3f°C, 10 min; all other digestions and DNAmanipulations 
were carried out as described 114, 161. DNA fragments were isolated 
from gels using NA4S DEAE-filter (Schleicher & Bchuell). Tnlns- 
formations wire done using 2 yl of ligation mix and 40-60 ~1 of 
competent cells in ice-chilled cuvcttcs (2 mm electrode gap) and elec- 
troporated at 2.0 kv, 25 yF. and 400 R with the Gene plser (Bio- 
Rad). Transfection of BILK-21 cells was done with 10 pup cDNAl/ 
NeolSBP using the calcium phosphate prxedure [17] as described [l6]. 
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Control transfections were carried out with IO ,ug pcDNAIMco and 
IOyg salmon sperm DNA. Cells were incubated for IG hand shocked 
with medium containing 15% glycerol. After 48 h, cells were split and 
grown for 24 h before starting Ci418 selection at 500 j&ml, 0418’ 
clones appeared after IO days. Clones synthesizing recombinant SBP 
were detected with an immunofiher lift assay using polyclonal SBP 
antibodies. Human SBP was purified as previously described [l8]. 
Recombinant SBP was partially-purified on Con A agarosc pre-cqui- 
librated at 4°C with 300 ml of 50 mlM TRIS-Cl, 100 mM NaCI, I mM 
CaCI,, MnCI, and MgC&, pH 8.0. After elution of the breakthrough 
peak, which did not contain steroid-binding activity, the column was 
washed, and recombinant SBP was eluled i:lth &he Sdme buifcr con- 
taining 200 mM methyl a-o-mannopyranosidc. Recombinant SBP, 
detected with ELlSA [I91 and filter [20] assays, was concentrated and 
dialysed in the ProDiCon (Biomolccular Dynamics). Samples (l-5 pg 
SBP) were taken for SDS-PAGE [2l] and transferred to nitroccllulosc 
membranes (cat# HAHY 304F0, Milliporc) in the Transblot ap- 
paratus (Bio-Rad). The Western blots were probed with goat anti-SBP 
and rabbit anti-goat IgG coupled to horseradish peroxidase. 
Scatchard analyses were carried out with the filter assay [20]. Competi- 
tion studies with other steroids were carried out by incubating 150~1 
of 20 nM recombinant SBP with 20 nM [‘HISa-DHT (Sa- 
dihydrotestostcrone) and IO-fold molar excess of radio-inert DHT, T, 
E:, E, (cstrone), P (progesterone), and F (cortisol). The extent of 
competition was expressed in percent relative to DHT, 
3. RESULTS 
3.1. Preparcction and cloning offragments I (5’ endfrug- 
menr) and 2 (middle jlagmenr) into pBluescripr II 
SK +/- 
Four PCR primers were made to amplify and clone 
these two fragments: sense primer 1, SAGGGAGAC- 
CGGAATTGGATCCACCATGGAGAGCAGAGG- 
CCCACTGGCT3’; antisense primer 2, S’GACAGAG- 
CACAGAATTGCCGCGGTCCAGCACCCACCGT- 
AAGCTG3’; sense primer 3, SAGGGAGACCGGA- 
ATTGCCGCGGCTGGATGATGGGAGATGGCA- 
g; and antisense primer 4, S’GACAGAGCACAGA- 
ATTGATGAGGCTGGGGAATGTCTCGGAG 3’. 
Primers 1 and 2 were used to amplify fragment I en- 
compassing adenine” to cytosine3” (Fig. 1). The under- 
lined sequence contains an NcoI site adjacent o the 
translation start codon, a BamHI site, and a ‘Prime’ 
element for efficient cloning of PCR-amplified DNA 
into ‘Prime’ vectors [22, 231. The underlined sequence 
Ncol (4 
(3) 
(4) 
I. Partial restriction map of SBP cDNA showing the newly Fig. 
created SsrII, the two &,RIII, and &coRl sites, Arrows indicaie posi- 
tions for the four PCR primers used in amplifying the 5’ end of’ the 
cDNA. Nuclcotide numbering, shown in parentheses, tarts at 
adcnine-*‘. 
of primer 2 contains the complementary prime cloning 
sequence for pDVEG’ and a cytosine (underlined) for 
site-directed mutagenesis at position 366. This silent 
mutation produces a new and unique SstII site in the 
cDNA for facilitating the cloning 01’ fragments in later 
steps. Primers 3 and 4 were used to amplify fragment 
2 from cytosine3” to thymine73’, including the muta- 
genic nucleotide at position 366 for introducing the 
WI1 site, and the natural EcoRI site at position 701. 
The underlined region contains ‘Prime’ sequences for 
cloning in pVEGT’ [23]. The relative position of all four 
PCR primers is shown in Fig. 1. Following amplifica- 
tion, fragments 1 and 2 were each cut back with T4 
DNA polymerase, gel purified, and cloned into 
pDVEG’ and pVEGT’, respectively. Restriction ana- 
lyses of purified plasmids confirmed the presence of 
both fragments (data not shown). The DNA sequences 
of the fragments agreed with the corresponding exons 
of the published gene sequence [3,4]. Recombinant 
pDVEG’ and pVEGT’ were each digested with BarnHI 
and &II, and SsrII and EcoRI, respectively. A three- 
part ligation consisting of fragments 1, 2, and BanzHl 
and EcoRI-digested pB1uescript II SK +/- was carried 
out followed by electroporation into DHIOB eels. The 
predicted 709 bp BanlHI-EcoRI, 376 bp BurnHI-SsrII, 
and 333 bp SsrII-EcoRI fragments were all obtained 
(data not shown). 
3.2. Subcloning offiagrnerzt 3 (‘the 3’ end fkgnlenr) 
Fragment 3 was obtained from a &tl 1 clone previ- 
ously isolated form a Hep G2 cDNA library by an 
immuno-screen (B.G. Que, F.S. Hagen and P.H. Petra, 
unpublished result). The EcoRI fragment of this clone 
was subcloned into lambda HG3 which contains 
pGEMT, pGEM-1 with a T7 RNA polymarase termi- 
nator [23]. A clone containing the SBP sequence was 
identified with a SBP-specific oligonucleotide probe. 
DNA was purified [24], and pGEMT contained in 
lambda HG3 was removed by the lambda-pop pro- 
cedure [22,23-J, This procedure liberated pGEMT hav- 
ing lVor1 termini and containing the SBP insert. After 
electroporation, the plasmid was amplified in DHlOB 
and fragment 3 was cxcized with EcoRI digestion. The 
DNA sequence revealed that fragment 3 contained the 
expected sequence from the internal EcoRI site 
(adenine”‘) to the terminal 3’end EcoRI site (Fig. 1). 
3.3. Gloning of full-Length SBP cDNA into pBhescript 
N SK +/- 
pBluescript II SK +/- containing fragments I and 2 
was linearized with EcoRI, dephosphorylated, and frag- 
ment 3 was cloned into the site. Fig. 2A and B show the 
presence of the predicted full-length cDNA of 1,267 bp 
released by &.w._~ . . .._ ._ . I-W -d GoI (lane 11) which inc!udzs 
34 bp from the cloning site of pBluescript, and 1,233 bp 
by partial f?oRI digestion of the BunzIiI linearized 
vector (lane 12). The predicted 709 bp and 532 bp 
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Neo for mammalian expression. Restriction analyses of 
the recombinant pcDNAI/Neo/SBP show the presence 
of the predicted 1,267 bp full-length cDNA released 
with BuntHI and XimI (lanes 6 and 7, Fig. 2A and B). 
Lane 7 of Fig. 2A and B also shows the predicted 376 
bp BrrntHIISsrII and 895 bp SstIUXhoI fragments. 
There are two vector bands in lane 7 of Fig. 2A that do 
not hybridize in the Southern blot of Fig. 28, one lo- 
cated below the linearized vector containing SBP and 
the other at about 1.1 kb. These arise from digestion at 
a second SsrII site in the vector. 
Fig. 2. Restriction analysis of clones containing full-length SBP 
cDNA. (A) 1.3% aSarose Sel: (lanes 1 and 14) ~HindlIl/~X174HasIII 
ladder; (lane 2) pcDNAI/Nco/SBP, uncut; (lane 3) pcDNAI/Nco, 
uncut; (lane 4) BmnHI-linearized pcDNAI/Nco/SBP; (lane 5) X~KII- 
linearized pcDNAI/Neo/SBP; (lane 6) BamHI- and XlroI-cut 
pcDNAI/Neo-SBP; (lane 7) BumHI-, XltoI- and SsrIl- cut pcDNAl/ 
Neo/SBP; (lane 8) pBluescript/SBP, uncut; (lane 9) BcmHI-linearized 
pBluescript; (lane 10) BajnHI-linearized pBlucscripUSBP; (lane II) 
BujnHI- and Xlrol.cut pBluescdpt/SBP; (lane 12) partial &coRI digest 
of L?a/nHI-linearized pBluescript/SBP; (lane 13) Bglll-cut pBluescript- 
SBP. (6) Southern blot of agarose gel shown in Fig. 24, with the same 
lane assignmcnls. The low background in vector DNA shown in lanes 
3 and 9 is due to contamination of the gel-purified SBP fragments with 
vector DNA during biotinylation (F.S. Hagen, unpublished results). 
3.5. Expression of SBP/ABP in BffK-21 cells: preiimi- 
nary characterization of the recombinant protein 
Stable G418’ BHK-21 clones were grown to estimate 
the extent of SBP expression. A total of 57 clones were 
identified by the immunofilter lift assay but only 5 
produced detectable steroid-binding activity. The 
average recombinant SBP levels secreted by these clones 
Table I 
The wells in both figures were marked with black ink. Relative steroid-binding affinity of recombinant SBP 
EcoRI fragments are also seen in lane 12, although the 
latter is barely noticeable in the Southern blot. The 
presence of a 537 bp &/II restriction fragment in lane 
13 confirms the correct orientation of fragment 3 (see 
Fig. 1). 
3.4. Cloning offuklength SBP-cDNA intopcDNAI/Neo 
The full-length SBP cDNA was moved into pcDNAI/ 
B/F 
11 K - 
-1 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 
Bound DMT (nM) 
Fip. 3. Scatchard analysis recombinant SBP. The coefficient of de- 
termination, r’ = 0.9s for the linear regression, y = -0.60 nM-‘)x + 
1.46 The inset shows a Western blot of human and recombinant SBP. 
Steroids Relative binding (8) 
Recombinant Human* 
Sa-Dihydrotestosterone 100 100 
Testosterone 50 33 
I7&Estradiol 41 21 
Estronc 0 I.3 
Progesterone 0 0.B 
Cortisol 0 0.7 
*Vermeulen and Verdonck [3 11, 
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at confluency were in the range of 0.2 peg SBP/ml 
medium. One such clone was grown to yield approxi- 
mately 1 S 1 of medium from which the secreted recom- 
binant protein was partially-purified. A K,, of 0.28 nM 
for the binding of DHT was calculated from the 
Scatchard plot of Fig. 3 which agrees completely with 
published values for the human protein [20,25,26]. The 
Western blot of Fig. 3 indicates aslightly faster mobility 
in SDS-PAGE for the recombinant protein and the 
presence of fewer isoforms. Table I shows the steroid- 
binding specificity of irecombinant SBP as follows: DHT 
> T > E? > E,, P, F, which agrees with the steroid- 
binding specificity of human SBP. 
4. DISCUSSION 
After several unsuccessful attempts at isolating a full- 
length SBP cDNA by screening libraries or amplifying 
the entire sequence by PCR, we decided to construct it 
from three smaller fragments, two amp!ified by PCR 
using Hep G2 poly(A)’ as template, and the other a Hep 
G2 ilgtl 1 cDNA clone containing the 3’ end sequence. 
This approach led to the isolation of a full-length cDNA 
which agrees completely with the protein [2] and gene 
sequence of Gershagen et al. [3], It is also consistent 
with that of Hammond et al, 143 except for guanine’” 
which they report as a cytosine. The presence of 
guanine5M encodes Leu”” instead of Phezs’ as reported 
by Hammond et al. [4,6], The Leuz59 assignment is 
correct on the basis of the protein sequence [2] and the 
finding of guanineeu by two independent labo- 
ratories((31 and this work). Expression of the SBP 
cDNA in BHK-21 cells, a mammalian cell line that 
expresses eukaryotic proteins [27,28], yields recom- 
binant SBP with a subunit molecular weight and 
steroid-binding properties imilar to human SBP. The 
‘&stern blot of Fig. 3 suggests that the extent of gly- 
cosylation is less pronounced than human SBP. Our 
objective was to test whether or not the full-length 
cDNA could yield active SBP in a mammalian cell line. 
Although this was achieved, the level of SBP expression 
was low. We have now expressed SBP cDNA in COS-7 
cells and find a level of expression at least IO-times 
higher which will permit site-directed mutagenesis ex- 
periments (L. Sui, W. Zhang, and P.H. Petra, unpub- 
lished results). 
The findings presented here open the way for study- 
ing SBP/ABP with a molecular biology approach. A 
number of outstanding questions remain with regards 
to the structure and function of SBP. Which structural 
parameters are responsible for dimer formation? Is the 
steroid-binding site located at the interface between the 
subunits? How many and which kind of amino acid 
side-chains are involved in sternid birtding? Does ?he 
monomer bind steroid? Lastly. &he recent proposal for 
the existence of an SBP F :Ibrane receptor [29, 301 
raises the question as to w%rr: on the surface of the SBP 
26 
LETTERS March 1992 
molecule does receptor interaction take place? Al- 
though recent findings indicate that fully deglycosylated 
human and rabbit SBPs have the same binding affinity 
for DHT as native SBP (P.H. Petra, P.R. GrifIin, L. 
Hood. K. Moore and W. Zhang, submitted for publica- 
tion), the oligosaccharide side-chains could play a role 
in SBP receptor recognition. Deglycosylated SBP or 
recombinant SBP having mutated carbohydrate attach- 
ment sites may be used to test this proposal. 
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